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ABSTRACT 
 Pachydermatoperiostosis, a rare form of  hypertrophic osteoarthropathy, is of 
unknown etiology and previously thought limited to humans.  The only periosteal 
reaction previously reported in prosimians is related to renal disease.  Notation of 25 
hypertrophic osteoarthritis in three prosimians led to recognition that this was the first 
non-human documentation of the disease.  Three related red ruffed lemurs (Varecia 
variegatus rubra) had diaphyseal periosteal reaction classic for hypertrophic 
osteoarthropathy.  Workup was negative for known underlying causes and for the 
secondary hyperparathyroidism which produces bone alterations in black Eulemur 30 
macao, black and white Varecia variegatatus varigatus and ringtail Lemur catta lemurs.   
Recognition of facial coarsening allows identification of the primary form  
of hypertrophic osteoarthropathy, categorized in humans as primary hypertrophic 
osteoarthropathy.  This is the first recognition of the phenomenon in the order primates, 
exclusive of humans, and represents a new model for this rare disease. 35 
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 Primary hypertrophic osteoarthropathy (PHOA), also referred to as 
pachydermoperiostitis and pachydermoperiostosis, is a rare disease, previously reported 
only in humans.1-5  While elimination of secondary causes for hypertrophic 
osteoarthropathy is part of the diagnostic approach, it is often the coarsening of facial 
features that suggests the diagnosis of the primary form.6   It presents in humans as 45 
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autosomal dominant with symptoms usually appearing around puberty.1,4,7  Recognition of 
the phenomenon in this group of related lemurs suggests the availability of this species as a 
new model for this baffling disease. 
 Prosimians, order primates, rarely develop bone pathology8,9 which, when noted, 
presents as irregular overgrowth of the outer layer of bone cortex, referred to as periosteal 50 
reaction.  Previously reported cases in black (Eulemur macao) and black and white 
(Varecia variegatus variegatus) lemurs10,11 have been related to the secondary 
hyperparathyroidism of renal disease and, in ringtail lemurs (Lemur catta), to nutritional 
secondary hyperparathyroidism.11  
 The findings in red ruffed lemurs (Varecia variegatus rubra) support a different  55 
diagnosis.  Examination of the character and distribution pattern of periosteal reaction in an 
adult female identified a phenomena well recognized in mammals, hypertrophic 
osteoarthropathy (HOA).12-14  Most HOA is secondary, a complication of intrathoracic 
pathology and liver disease.15-19   However, after an exhaustive workup identified none of 
the known causes in the propositus, one of us (DN) commented that her subsequently-60 
affected daughters had the same facial coarsening.  This led to the recognition that these 
lemurs actually represented the first animal model of the primary form of HOA.1-3,20 
MATERIALS AND METHODS 
 Affected lemurs underwent full clinical, laboratory and radiologic evaluation to 
characterize the underlying disease process and to seek an effective approach to its 65 
treatment.  Autopsy was performed on the propositus. 
RESULTS 
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Case 1 
 
 An 8 year old, 3.5 kg, female red ruffed lemur (Varecia variegatus rubra, lemur 1, 70 
propositus) was hand-restrained for examination to evaluate reported lethargy and hind leg 
stiffness.   Physical examination was unremarkable, with exception of decreased muscle 
mass.  Complete blood count (CBC) and serum chemical assays were within normal 
species range,21 with exception of globulin [3.6 gm/dl, ISIS (International Species 
Inventory System) range = 1.9 + 0.7 gm/dl] and albumin (3.2 gm/dl, ISIS range = 5.7 + 0.8 75 
gm/dl).    Evaluation 6 weeks later revealed decreased total red blood cell count (RBC) (7.8  
x 106/UL, ISIS range 9.31 + 1.01 x106/UL), and phosphorus (2.8 mg/dl, ISIS range 5.9 + 
1.8) levels.  Bile acids levels were 1mcmol/L (considered normal, based on the range for 
domestic dogs of 0.1-15 mcmol/L).  At the time of the third evaluation, RA latex test, 
antinuclear antibody and direct Coombs were negative/normal.  80 
 Accentuated stiffness and hunched back posturing were episodically noted over the 
next 4.5 years, leading to immobility and requirement for hand feeding.  Six years after 
initial presentation, she was noted to have dull, rough pelage, reduced muscle mass and 
palpable osseous thickening.  Radiographs revealed diffuse periosteal reaction of long 
bones, originating at distal diaphyses (Figures 1,2).  Laboratory evaluation revealed 85 
negative/normal CBC, calcium, parathormone, 25-hydroxy vitamin D, thyroid tests, BUN, 
creatinine, liver function test, electrocardiogram, cardiac ultrasound, treponemal rapid 
plasma reagin card test and fluorescent treponemal antibody-absorption test. Abnormalities 
in alkaline phosphatase (ALP) were detected and were characterized as fluctuating, but 
progressively increasing values, ranging from 663- 2200 IU/L (ISIS range 410 + 233 90 
IU/L).  
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Naproxen (62.5 mg bid) and flurbiprofen (12.5 mg tid) were without benefit.  
Meclofenamic acid (0.5g-1 mg/kg) and a short course of prednisone (1mg/kg) provided 
minimal benefit.  Progressive worsening in symptoms and peripheral skeleton bony 
proliferation over the ensuing 18 months and brow rim prominence were accompanied by 95 
maxillary and mandibular gingival proliferation and reduction of ankle range of motion by 
50%. Treatment with bicillin (50,000 IU procaine penicillin and 50,000 IU benzathine 
penicillin doses intramuscularly), for possibility of yaws, resulted in no benefit. Ten 
months later, hind limb weakness, tremor and reluctance to move were noted.   
Sulfasalazine (90 mg bid) treatment resulted in increased mobility and activity, but 100 
did not halt radiologic progression.  In addition, rounded caps had developed on the dorsal 
spinal processes of 6 lumbar vertebrae and brow ridges became more prominent (Figures 
3,4).  Severe stiffness and immobility subsequent to 8.25 additional years of followup led 
to euthanasia. 
Significant gross necropsy findings were limited to the skeletal system. Severe 105 
bony proliferation was palpated on all long bones, the mandible, maxilla, and brow ridge 
as well as a prominent ridge of bony proliferation was present on gingival dental margin.  
Histopathology revealed bony proliferation (hyperostosis) characterized by bony 
trabeculae with an increased number of disorganized, irregularly shaped and contoured 
cement lines.  Mild emphysema, mild splenic hemosiderosis and moderate small intestine 110 
hemosiderosis were also identified. 
Case 2  
A 9 year old, 3.13 kg, female red ruffed lemur (lemur 2, offspring of propositus) 
(100290) was anesthetized for examination due to recent episodes of stiffness and to screen 
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for skeletal changes as seen in its dam (lemur 1, propositus).  Physical examination was 115 
unremarkable.  CBC and metabolic panel were unremarkable, with exception of alkaline 
phosphatase of 678.  Radiographs revealed significant proliferative changes in both tibia 
and severe proliferative changes in both radii and ulnas.   
Episodes of stiffness and/or lamness occurred with increased severity occurred over 
the next 6.5 years with progressive increasing ALP to >1989   During this time period 120 
various treatments (ibuprofen, acetaminophen, sulfasalzine,  cosequin, tramadol) were 
prescribed to address discomfort with variable benefit. Limited progression of radiographic 
lesions was appreciated in followup films. At age 16.5 years the lemur was euthanized due 
to non-responsive diarrhea.  Necropsy information was not available. 
Case 3 125 
An 9 year old, 2.83 kg, female red ruffed lemur (lemur 3, offspring of propositus) 
was anesthetized for routine examination and to screen for the skeletal disease detected in 
its dam (lemur 1) and sibling (lemur 2).   Physical examination was unremarkable. 
Radiographs revealed periosteal proliferation in both tibia and distal right radius.  CBC and 
SBA were normal, with exception of phosphorus 9.6 mg/ml.  130 
Three months later, the lemur was reluctant to move and hindlimb trembling was 
noted. When the animal did ambulate, she appeared to be favoring the right foot. Physical 
examination was unremarkable and radiographs revealed no progression of the periosteal 
reaction.  CBC and metabolic panel were unremarkable.  CPK was 34,547.  Radiographs 
revealed early periosteal reaction.  135 
Eight months later the animal was noted to be thin with prominent muscle wasting.  
Firm thickening was palpable along the tibia and ulna bilaterally. Radiographs 
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demonstrated a progression of lesions with hyperosotosis present along the caudolateral 
aspect of the proximal 1/3 of both ulna and along the cranial aspect of the proximal 1/2 of 
both tibiae.  Normal ALP (463) and elevated BUN (46) were noted.  140 
Episodes of stiffness and/or lamness occurred over the next 6.5 years with 
increased severity noted at age 16 yrs.  Starting at age 11, ALP progressively increased to 
1786. During this time period various treatments (ketoprofen  sulfasalzine,  
chondroitin/glucosamine) were prescribed to address discomfort, with variable benefit. 
Limited progression of radiographic lesions was present in followup films, although 145 
increase brow prominence did develop similar to propositus.  At age 17 years, the lemur 
was euthanized due to marked increase in discomfort and difficulty in moving or righting 
itself.   Necropsy information was not available.  
DISCUSSION  
Diagnosis 150 
 The ruffed lemurs clearly had hypertrophic osteoarthropathy (HOA).  They had 
generalized long bone periosteal reaction.  Distal diaphyses were invariably affected, as 
has been documented in human HOA.19   Hypertrophic osteoarthropathy is characterized in 
humans by a widespread pattern of periosteal reaction.12-19  Although HOA is traditionally 
described as a disorder of distal diaphyses, more extensive disease is also noted. Periosteal 155 
reaction is found to be equally divided between distal and diffuse apposition.19   
Localization or diffuseness of periosteal reaction in the tibia does not correlate with 
severity of disease, extent of skeletal involvement, or which bone groups are affected in 
humans.  The average number of affected bone groups in humans is 3.9.  [Involvement of 
one or both tibia(e) are considered as a single bone group].  160 
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Underlying causes of secondary hypertrophic osteoarthropathy include pulmonary, 
gastrointestinal/esophageal, cardiac, or hepatic disease (usually abdominal or thoracic 
masses or lesions) are present.12-18  None of the lemurs described in this report had 
radiographic evidence of a visceral neoplastic condition, nor was there evidence of non-
skeletal disease based on serum liver function analysis.  Antemortem cardiac evaluation 165 
(EKG and ultrasound) of the propositus, as well as gross and histological evaluation failed 
to show evidence or neoplasia or visceral disease. 
The diagnosis of primary hypertrophic osteoarthropathy (pHOA), also called 
pachydermoperiostosis,2-5,12 was made when unique facial features were recognized in the 
propositus and her two daughters.  Furrowing/thickening of facial features was noted 170 
(Figures 3,4), often referred to as pachydrmia and cutis vertices gyrata in humans.6  Based 
on the above evidence/diagnostic results, the lemurs were considered to have PHOA. 
Pachydermoperiostosis is a rare inherited disease that accounts for 3-5% of all cases of 
HOA in humans.7   The disease exists in three forms: complete (periostosis and 
pachydermia), incomplete (without pachydermia), and the forme fruste (pachydermia with 175 
minimal skeletal changes).  As the name implies, it is usually recognized when cutaneous 
lesions such a pachydermia, seborrhea, (skin changes causing coarse facial features with 
thickening, furrowing and excessive oiliness of the skin of face forehead, leading to 
acromegalic-like faces in adults), digital clubbing, and rarely cutis vertices gyrata occur.4 
Bone and joint involvement includes arthralgia, arthritis, periosteal new bone formation , 180 
subperiosteal ossification and osteoporosis.4.5.7.14  Gastric mucosa hypertrophy, gastric 
ulcer and other endocrine abnormalities have been described.22   PHOA may take up to 20 
years for full development of symptoms in humans.4 
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Pachydermoperiostosis demonstrates an autosomal dominant mode of inheritance 
with variable penetrance in humans and a predilection for males predominance (over 185 
females) (7:1). Symptoms usually appear around puberty, with males generally more 
severely affected.1,4,7  All lemurs affected in this report were females.  It is of interest that 
the daughters of the propositus became affected at roughly the same age, while their male 
same age siblings remained disease free.    
The pathogenic mechanism of PHOA is unknown. In addition to genetic influences, 190 
proposed etiological factors include anomalies in fibroblast activity or alteration of 
peripheral blood flow.1,4    Support for the latter includes tortuous capillaries (as seen on 
nail bed capillaroscopy, capillarorhexis, microhematomas) and diffuse plasmatic and red 
blood cell extravasation.5 
Differential diagnosis 195 
Proliferative bone diseases are uncommon in nonhuman primates.8  Prior to this 
report, the only bone disease with a solely adult onset that has been thoroughly described 
in lemurs is a familial condition of periarticular hyperostosis, seen in black lemurs 
(Eulemur macaco macaco)10 and in black and white lemurs (Varecia variegatatus 
varigatus).11   This contrasts with the disease observed in red ruffed lemurs, which was not 200 
limited to the periarticular region.  They had generalized periosteal reaction, but no the 
facial bone proliferation of the form of craniodiaphyseal dysplasia referred to as lioniasis 
or lionitis.23 
Differential diagnosis must consider infectious disease (e.g., treponemal), 
endocrinopathies with or without nutritional imbalances (e.g., thyroid acropachy, 205 
acromegaly and renal osteodystrophy or secondary hyperparathyroidism and 
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osteomalacia), neoplasia and hypertrophic osteoarthropathy.14-18  Although infection of 
bones or surrounding tissues can cause pronounced periosteal proliferation, no evidence of 
an infectious process was seen in the CBC, radiographs or bone biopsies.  In humans, 
infection with Treponema pallidum subsp. pertenue, the causative agent of yaws, a non-210 
venereal treponematosis, can cause marked periostitis.14,24   The possibility of treponemal 
infection was investigated in the propositus, but serological testing revealed no evidence of 
disease. As the tests have not been validated for non-human primates, a clinical treatment 
trial for possible yaws was initiated. It had no effect and post-mortem evaluation revealed 
no evidence of treponemal or other infectious agents. 215 
Several endrocrinopathies were investigated.  Thyroid acropachy causes a 
characteristic overgrowth of bone, probably related to overproduction of a long acting 
thyroid-stimulating hormone.  It is easily ruled out, as it is disorder of the distal 
extremities, predominantly affected hands and feet,14,18,25 areas that were not affected in the 
red ruffed lemurs.  Similarly, acromegaly can be ruled out on the basis of absence of 220 
abnormalities of the distal portion of the extremities and of pituitary changes.18  Although 
primary hyperparathyroidism has not been reported in prosiminans,8  secondary 
hyperparathyroidism has been reported in black lemurs10 and was initially considered the 
possible diagnosis.   Hyperparathyroidism of any form (primary or secondary) was ruled 
out on the basis of normal calcium and absence of elevated phosphate levels and similar 225 
calcium and parathormone levels in affected and unaffected lemurs.  Further evidence 
against secondary hyperparathyroidism includes lack of azotemia or osteomalacia and 
indistinguishable levels of 25-hydroxy vitamin D in affected and unaffected lemurs.  
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Paget’s disease alters the size and shape of bones and producesa characteristic 
resorption pattern, in addition to the histologic findings of woven bone, cement lines, 230 
marrow fibrosis and increased marrow vascularity.14,18  Cement lines and woven bone are 
non-specific, in the absence of the above-mentioned macroscopic/radiologic findings.  
Weber et al.9 suggested possibility of Paget’s disease in lemurs, because histology revealed 
prominent disorganized cement lines.  However, such changes are non-specific and Paget’s 
disease does not cause periosteal reaction.  Thus, Paget’s disease need not be further 235 
considered in the differential diagnosis of the ruffed lemur pathology. 
Pathophysiology of disease 
Variable serum ALP in affected ruffed lemurs appeared to correlate with disease 
activity.  Bone alkaline phosphatase is a product of osteoblasts. The osteoproliferative 
process in the propositus may have been identified near the end of an active phase, 240 
explaining the subsequent decrease in measured ALP. 
What is the significance of CPK in affected lemurs.  Most values were within 
normal range, although phenomenal elevation was noted in one individual (CPK = 34,547).  
Myocardial infarction has not been previously recognized in lemurs.8 Myocarditis was a 
consideration but, if present, has no known association with HOA and was not found at 245 
autopsy.. 
Treatment 
Conventional therapy for PHOA in humans is anecdotal.1,7  It is unclear that any 
have actually proven of reproducible benefit.  Analgesics, NSAIDS, colchicine, and oral or 
intraarticular steroids have been used with minimal benefit. This contrasts with the 250 
effectiveness of sulfasalazine in treatment of the unrelated disorder, spondyloarthropathy.26  
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More recently, bisphosphonates (e.g., pamidronate, administered intravenously) have been 
tried, with mixed results.7  Future cases of PHOA in lemurs may benefit from intravenous 
pamindronate (a biphosphonate), although minimal benefit was noted when applied herein. 
CONCLUSIONS 255 
The proliferative bone disease seen in these three ruffed lemurs appears to be a 
unique condition not previously described in nonhuman primates.  The only bone disease 
with an adult onset that has been described in lemurs is a familial condition, renal 
osteodystrophy, seen in black (Eulemur macaco macaco) and in black and white lemurs 
(Varecia variegatus varigatus).  The initial workup of the animals in this report did not 260 
lead to a definitive diagnosis.  However, the presence of proliferative bone disease and 
elevated alkaline phosphatase with no other apparent metabolic derangements is most 
similar to PHOA as seen in humans.  The apparent familial nature of this phenomenon in 
red ruffed lemurs is analogous to the limited (lower extremity in absence of digital 
clubbing) form reported in 3 members of a human family.21   265 
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    Figure Legends 
Figure 1:  Posterior-anterior x-ray view of forearms.   Note massive new periosteal 
 bone formation. 
Figure 2:  Oblique x-ray view of tibiae and fibulae.   Note new periosteal bone 
 formation. 340 
Figure 3:   Anterior view of facial features.  A.  Upper left - normal sibling of affected 
 daughters.  B.  Upper right – propositus.  C.  Lower left - first daughter.  D.  Lower  
 right - second daughter. 
Figure 4:  Later view of facial features.  A. Upper left - normal sibling of affected 
 daughters.  B.  Upper right – propositus.  C.  Lower left - first daughter.  D.  Lower 345 
 right - second daughter. 
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